Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2016, Article ID 5385972, 8 pages
http://dx.doi.org/10.1155/2016/5385972
Review Article

Autologous Graft-versus-Tumor Effect: Reality or Fiction?

Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

Received 17 May 2016; Revised 8 July 2016; Accepted 25 July 2016

Academic Editor: Jan S. Moreb

Copyright © 2016 Luis F. Porrata. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Gill and D. L. Porter, “Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect,” Annual Review of Medicine, vol. 64, pp. 101–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-J. Chang and X.-J. Huang, “Donor lymphocyte infusions for relapse after allogeneic transplantation. When, if and for whom?” Blood Reviews, vol. 27, no. 1, pp. 55–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Powles, S. Singhal, J. Treleaven, S. Kulkarni, C. Horton, and J. Mehta, “Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation,” Blood, vol. 91, no. 9, pp. 3481–3486, 1998. View at Google Scholar · View at Scopus
  4. Z. S. Pavletic, S. S. Joshi, S. J. Pirruccello et al., “Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies,” Bone Marrow Transplantation, vol. 21, no. 1, pp. 33–41, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. L. F. Porrata, M. A. Gertz, D. J. Inwards et al., “Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma,” Blood, vol. 98, no. 3, pp. 579–585, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L. F. Porrata, D. J. Inwards, S. M. Ansell et al., “Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-hodgkin lymphoma: a prospective study,” Biology of Blood and Marrow Transplantation, vol. 14, no. 7, pp. 807–816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Valtola, V. Varmavuo, A. Ropponen et al., “Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance,” Leukemia and Lymphoma, vol. 57, no. 9, pp. 2025–2032, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Rueff, M. Medinger, D. Heim, J. Passweg, and M. Stern, “Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma,” Biology of Blood and Marrow Transplantation, vol. 20, no. 6, pp. 896–899, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. L. F. Porrata, D. J. Inwards, I. N. Micallef et al., “Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas,” Clinical and Developmental Immunology, vol. 2010, Article ID 914945, 13 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Taverna, S. G. Yun, J. Jonnadula et al., “Role of maintenance therapy after high-dose chemotherapy and autologous hematopoietic cell transplantation in aggressive lymphomas: a systemic review,” Biology of Blood and Marrow Transplantation, vol. 22, no. 7, pp. 1182–1196, 2016. View at Publisher · View at Google Scholar
  11. L. F. Porrata, D. J. Inwards, S. M. Ansell, and I. N. Micallef, “Day 15 peripheral blood lymphocyte/monocyte ratio post-autologous peripheral hematopoietic stem cell transplantation and survival in diffuse large B-cell lymphoma,” Journal of Stem Cell Research & Therapy, vol. 1, article 103, 2011. View at Publisher · View at Google Scholar
  12. K. Ansell and L. F. Porrata, “Autograft monocytes: the bad humors of autologous peripheral blood hematopoietic stem cell transplantation,” Journal of Stem Cell Research & Therapy, supplement 3, article 005, 2013. View at Publisher · View at Google Scholar
  13. L. F. Porrata, J. N. Ingle, M. R. Litzow, S. Geyer, and S. N. Markovic, “Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer,” Bone Marrow Transplantation, vol. 28, no. 9, pp. 865–871, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. L. F. Porrata, D. J. Inwards, I. N. Micallef, S. M. Ansell, S. M. Geyer, and S. N. Markovic, “Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease,” British Journal of Haematology, vol. 117, no. 3, pp. 629–633, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. L. F. Porrata, M. R. Litzow, A. Tefferi et al., “Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia,” Leukemia, vol. 16, no. 7, pp. 1311–1318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Ferrandina, L. Pierelli, A. Perillo et al., “Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications,” Clinical Cancer Research, vol. 9, no. 1 I, pp. 195–200, 2003. View at Google Scholar · View at Scopus
  17. L. N. Gordan, M. W. Sugrue, J. W. Lynch, K. D. Williams, S. A. Khan, and J. S. Moreb, “Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma,” Bone Marrow Transplantation, vol. 31, no. 11, pp. 1009–1013, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Nieto, E. J. Shpall, I. K. McNiece et al., “Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant,” Clinical Cancer Research, vol. 10, no. 15, pp. 5076–5086, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kim, H.-J. Sohn, S.-E. Kim et al., “Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma,” Bone Marrow Transplantation, vol. 34, no. 1, pp. 43–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. F. Porrata, M. A. Gertz, M. R. Litzow et al., “Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis,” Clinical Cancer Research, vol. 11, no. 3, pp. 1210–1218, 2005. View at Google Scholar · View at Scopus
  21. H. Kim, H.-J. Sohn, S. Kim, J.-S. Lee, W.-K. Kim, and C. Suh, “Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma,” Bone Marrow Transplantation, vol. 37, no. 11, pp. 1037–1042, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. R. Boulassel, A. L. Herr, M. D. deB Edwards et al., “Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders,” Hematology, vol. 110, pp. 165–170, 2006. View at Google Scholar
  23. C. Joao, L. F. Porrata, D. J. Inwards et al., “Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma,” Bone Marrow Transplantation, vol. 37, no. 9, pp. 865–871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Dean, P. Masci, B. Pohlman et al., “Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival,” Bone Marrow Transplantation, vol. 36, no. 12, pp. 1049–1052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Schmidmair, N. Oversohl, B. Schnabel et al., “Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients,” Experimental Oncology, vol. 30, no. 3, pp. 240–243, 2008. View at Google Scholar
  26. L. F. Porrata, D. J. Inwards, S. M. Ansell et al., “Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma,” Biology of Blood and Marrow Transplantation, vol. 20, no. 11, pp. 1804–1812, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. L. F. Porrata, D. J. Inwards, S. M. Ansell et al., “Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma,” Journal of Blood Medicine, vol. 6, pp. 45–53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L. F. Porrata, D. J. Inwards, S. M. Ansell et al., “Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation,” Journal of Hematology & Oncology, vol. 8, article 80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. L. F. Porrata, E. A. Burgstaler, J. L. Winters et al., “Immunologic autograft engineering and survival in non-Hodgkin lymphoma,” Biology of Blood and Marrow Transplantation, vol. 22, no. 6, pp. 1017–1023, 2016. View at Publisher · View at Google Scholar
  30. L. F. Porrata and S. N. Markovic, “Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation,” Clinical and Experimental Medicine, vol. 4, no. 2, pp. 78–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. F. Porrata, M. R. Lotzow, D. J. Inwards et al., “Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma,” Bone Marrow Transplantation, vol. 33, no. 3, pp. 291–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. F. Porrata, M. A. Gertz, S. M. Geyer et al., “The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma,” Leukemia, vol. 18, no. 6, pp. 1085–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. D. K. Hiwase, S. Hiwase, M. Bailey, G. Bollard, and A. P. Schwarer, “Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma,” Biology of Blood and Marrow Transplantation, vol. 14, no. 1, pp. 116–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. F. Porrata and S. N. Markovic, “Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation,” World Journal of Clinical Oncology, vol. 1, no. 1, pp. 29–34, 2010. View at Publisher · View at Google Scholar
  35. C. L. Mackall, T. A. Fleisher, M. R. Brown et al., “Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy,” The New England Journal of Medicine, vol. 332, no. 3, pp. 143–149, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. S. G. Holtan, L. F. Porrata, D. J. Inwards et al., “Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma,” British Journal of Haematology, vol. 133, no. 6, pp. 628–633, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. L. F. Porrata, S. R. Hayman, M. A. Gertz et al., “The role of stem cell mobilization regimen on lymphocyte collection yield and survival after autologous hematopoietic stem cell transplantation in multiple myeloma,” Blood, vol. 106, abstract #1174, 2005. View at Google Scholar
  38. D. K. Hiwase, S. Hiwase, M. Bailey, G. Bollard, and A. P. Schwarer, “The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma,” Cytotherapy, vol. 10, no. 5, pp. 507–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. K. Kim, S. Kim, S. S. Lee et al., “Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP,” Transfusion, vol. 47, no. 8, pp. 1447–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Luyckx, E. Schouppe, O. Rutgeerts et al., “G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells,” Clinical Immunology, vol. 143, no. 1, pp. 83–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Rutella, G. Bonanno, L. Pierelli et al., “Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-α,” European Journal of Immunology, vol. 34, no. 5, pp. 1291–1302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Holtan, L. F. Porrata, I. N. M. Micallef et al., “AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantion in non-Hodgkin lymphoma,” Clinical Lymphoma & Myeloma, vol. 7, no. 4, pp. 315–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Gazitt, C. O. Freytes, C. Akay, K. Badel, and G. Calandra, “Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients,” Stem Cells and Development, vol. 16, no. 4, pp. 657–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Gaugler, J. Arbez, S. Legouill et al., “Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone,” Cytotherapy, vol. 15, no. 7, pp. 861–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. Sosman, P. Stiff, S. M. Moss et al., “Pilot trial of interleukin-2 with granulocyte colony stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion,” Journal of Clinical Oncology, vol. 19, no. 3, pp. 634–644, 2001. View at Google Scholar · View at Scopus
  46. T. A. Fehniger and M. A. Caligiuri, “Interleukin 15: biology and relevance to human disease,” Blood, vol. 97, no. 1, pp. 14–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Parrish-Novak, S. R. Dillon, A. Nelson et al., “Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function,” Nature, vol. 408, no. 6808, pp. 57–63, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. Ø. Bruserud and E. Ulvestad, “Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia,” Journal of Interferon & Cytokine Research, vol. 20, no. 11, pp. 947–954, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. O. Dienz and M. Rincon, “The effects of IL-6 on CD4 T cell responses,” Clinical Immunology, vol. 130, no. 1, pp. 27–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. Ø. Wendelbo, N. Glenjen, and Ø. Bruserud, “Interleukin-7 (IL-7) in patients receiving intensive chemotherapy for acute myelogenous leukemia: studies of systemic IL-7 levels and IL-7 responsiveness of circulating T lymphocytes,” Journal of Interferon & Cytokine Research, vol. 22, no. 10, pp. 1057–1065, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Sheikh, B. O. Porter, R. DerSimonian et al., “Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia,” Blood, vol. 127, no. 8, pp. 977–988, 2016. View at Publisher · View at Google Scholar
  52. T. J. Fry and C. L. Mackall, “Interleukin-7: from bench to clinic,” Blood, vol. 99, no. 11, pp. 3892–3904, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. Ç. A. Akkök, K. Liseth, I. Nesthus et al., “Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation,” Transfusion, vol. 48, no. 5, pp. 877–883, 2008. View at Publisher · View at Google Scholar · View at Scopus